ArticlePLOS global public health2026
Prevalence of CMV, EBV, HPV, and HSV among South Asian healthy population: A systematic review and meta-analysis.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytomegalovirus (CMV), Epstein-Barr virus (EBV), Human papillomavirus (HPV), and Herpes simplex virus (HSV) are DNA viruses which are highly prevalent among the general population. Although the prevalence of each of these viruses has been studied separately within South Asian populations, there are no studies regarding the pooled prevalence of these viruses among healthy individuals across South Asia. A systematic search was performed using three databases (PubMed, Scopus, and Cochrane Library) and one search engine (Google Scholar) for original studies on the South Asian population (published from 2000 to 2025). Following the search, DerSimonian-Laird random effect meta-analysis was performed to calculate the overall prevalence of CMV, EBV, HPV, and HSV in South Asia. Based on our eligibility criteria, we found 94 studies from 7 South Asian countries comprising 162,659 healthy individuals. The overall pooled prevalence of the four viruses was 20% [95% CI: 16% to 24%]. The prevalence of the studies ranged from 0% to 100% indicating a significant amount of heterogeneity (I2 = 100%; p < 0.01). The highest pooled prevalence was of CMV (57%; 95% CI: 21% to 89%) followed by EBV (17%; 95% CI: 5% to 34%), HPV (13%; 95% CI: 10%. to 16%), and HSV (9%; 95% CI: 16% to 12%). Furthermore, country-wise analysis showed India to have the majority of the studies. Our findings revealed that 20% [95% CI: 16% to 24%] of healthy individuals who lived in different South Asian countries are infected with one of these DNA viruses, emphasizing the widespread impact across different geographical regions. As these infections can lead to severe health complications, it is crucial to establish preventive guidelines and spread awareness among the healthy population.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.